These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16397176)

  • 41. [New international guidelines on antithrombotic therapy in atrial fibrillation].
    Tveit A
    Tidsskr Nor Laegeforen; 2009 Jun; 129(13):1332-5. PubMed ID: 19561659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Warfarin and stroke outcomes in hemodialysis patients with atrial fibrillation.
    Genovesi S; Santoro A
    J Am Soc Nephrol; 2009 Oct; 20(10):2090-2. PubMed ID: 19713302
    [No Abstract]   [Full Text] [Related]  

  • 43. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rethinking warfarin for atrial fibrillation.
    Med Lett Drugs Ther; 2013 Sep; 55(1426):77. PubMed ID: 24081386
    [No Abstract]   [Full Text] [Related]  

  • 45. The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis.
    Gerson LB; Triadafilopoulos G; Gage BF
    Am J Med; 2004 Apr; 116(7):451-9. PubMed ID: 15047034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.
    Van Spall HG; Wallentin L; Yusuf S; Eikelboom JW; Nieuwlaat R; Yang S; Kabali C; Reilly PA; Ezekowitz MD; Connolly SJ
    Circulation; 2012 Nov; 126(19):2309-16. PubMed ID: 23027801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case report of a patient carrying CYP2C9*3/4 genotype with extremely low warfarin dose requirement.
    Lee SY; Nam MH; Kim JS; Kim JW
    J Korean Med Sci; 2007 Jun; 22(3):557-9. PubMed ID: 17596671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.
    Hansen ML; Sørensen R; Clausen MT; Fog-Petersen ML; Raunsø J; Gadsbøll N; Gislason GH; Folke F; Andersen SS; Schramm TK; Abildstrøm SZ; Poulsen HE; Køber L; Torp-Pedersen C
    Arch Intern Med; 2010 Sep; 170(16):1433-41. PubMed ID: 20837828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Timing of anticoagulation therapy in patients with acute cardioembolic stroke.
    Yamagami H; Toyoda K
    Circ J; 2015; 79(4):763-5. PubMed ID: 25753856
    [No Abstract]   [Full Text] [Related]  

  • 50. Time in the Therapeutic Range for Patients Taking Warfarin in Clinical Trials: Useful, but Also Misleading, Misused, and Overinterpreted.
    Reiffel JA
    Circulation; 2017 Apr; 135(16):1475-1477. PubMed ID: 28416519
    [No Abstract]   [Full Text] [Related]  

  • 51. Atrial Fibrillation and Stroke: It's About Point of View.
    Anderson DC; Asinger RW
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1118-9. PubMed ID: 25935313
    [No Abstract]   [Full Text] [Related]  

  • 52. Summaries for patients. What is the appropriate level of blood-thinning medication for elderly people with atrial fibrillation?
    Ann Intern Med; 2004 Nov; 141(10):I38. PubMed ID: 15545670
    [No Abstract]   [Full Text] [Related]  

  • 53. Home monitoring of warfarin effects.
    Lippi G; Franchini M
    N Engl J Med; 2011 Jan; 364(4):378; author reply 378-9. PubMed ID: 21268733
    [No Abstract]   [Full Text] [Related]  

  • 54. International Normalized Ratio Control in Patients With Atrial Fibrillation and CKD.
    Genovesi S; Carrero JJ
    Am J Kidney Dis; 2017 Jun; 69(6):863. PubMed ID: 28427792
    [No Abstract]   [Full Text] [Related]  

  • 55. Letter by Zito et Al regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham atrial fibrillation treatment of the aged study)".
    Zito S; Lattanzio F; Di Nisio M
    Stroke; 2014 Sep; 45(9):e191. PubMed ID: 25096728
    [No Abstract]   [Full Text] [Related]  

  • 56. In Reply to 'International Normalized Ratio Control in Patients With Atrial Fibrillation and CKD'.
    Jun M; Hemmelgarn BR
    Am J Kidney Dis; 2017 Jun; 69(6):863-864. PubMed ID: 28427791
    [No Abstract]   [Full Text] [Related]  

  • 57. Interactions Between Warfarin and Prednisolone: A Case Report.
    Peng TR; Lee LL; Wu TW
    Am J Ther; 2017; 24(4):e494. PubMed ID: 27849633
    [No Abstract]   [Full Text] [Related]  

  • 58. Is there a period of liability with initiation of warfarin in patients with atrial fibrillation?
    Diener HC; Granger CB; Patel MR
    Eur Heart J; 2014 Jul; 35(28):1834-5. PubMed ID: 24561547
    [No Abstract]   [Full Text] [Related]  

  • 59. Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".
    Mavaddat N; Roalfe A; Fletcher K; Lip GY; Hobbs FD; Fitzmaurice D; Mant J
    Stroke; 2014 Sep; 45(9):e192. PubMed ID: 25096732
    [No Abstract]   [Full Text] [Related]  

  • 60. Ischemic Stroke Mandates Cross-Disciplinary Collaboration.
    Fisher M; Hill JA
    Stroke; 2018 Feb; 49(2):273-274. PubMed ID: 29311266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.